Analysis of facial movements in response to light and sound stimulation during ultrasound scans may help diagnose Prader‐Willi syndrome…
Articles by Alice Melão
Inversago Pharma has raised $7 million to support the development of a new generation of cannabinoid-1 (CB1) receptor blockers…
Results from a Phase 2 clinical trial show that Levo Therapeutics’ lead therapy candidate, LV-101 (intranasal carbetocin), can effectively…
Zafgen‘s investigative therapy ZGN-1258, under development as a treatment for Prader-Willi syndrome, is being evaluated in preclinical…
The Gairdner Foundation recently announced the 2018 Canada Gairdner awardees for $100,000 prizes that recognize important research and biomedical discoveries.
Diazoxide helps reduce weight, body fat, and improve blood glucose levels and endurance capacity, in mice models of Prader-Willi syndrome…
Long-term use of growth hormone therapy in young adults with Prader-Willi syndrome (PWS) fails to prevent bone deterioration. But a…